Mike is well-respected by his colleagues and clients. He is the consummate mentor and has challenged and inspired many people throughout his career. All of us at Kantar Health are proud that he has received this recognition.
New York, NY (PRWEB) August 01, 2013
Kantar Health, a leading global healthcare consulting firm, is pleased to announce that Kantar Health Americas CEO Mike Kelly has been honored as part of the 2013 PharmaVOICE “100 Most Inspiring People,” an annual recognition in the publication’s July/August edition.
Each year, PharmaVOICE recognizes 100 professionals in the healthcare industry who inspire and motivate others; who have the greatest influence on corporate leadership, research and development, technology, creativity, marketing and strategy; and who impact the life-sciences industry through their actions.
As CEO of Kantar Health Americas, Mr. Kelly leads a multidisciplinary team that spans the full range of healthcare expertise across clinical and commercial, including health outcomes, market access and oncology. His current focus is aligning the team to bring together these experts to deliver deeper client insights and comprehensive solutions to client needs.
PharmaVOICE notes that Mr. Kelly's respectful acknowledgement of the challenges and concrete vision of the future are helping motivate his team to reach a collective goal.
“I am honored to be chosen by PharmaVOICE for their top 100 list this year,” Mr. Kelly said. “I feel fortunate to work with such a talented and innovative team of people at Kantar Health, who inspire me every day.”
Kantar Health Global CEO Lynnette Cooke said, “Mike is well-respected by his colleagues and clients. He is the consummate mentor and has challenged and inspired many people throughout his career. All of us at Kantar Health are proud that he has received this recognition.”
Mr. Kelly is a past president of the Pharmaceutical Market Research Group and speaks at many industry conferences.
About Kantar Health
Kantar Health is a leading global healthcare consulting firm and trusted advisor to many pharmaceutical, biotech, and medical device and diagnostic companies worldwide. It combines evidence-based research capabilities with deep scientific, therapeutic and clinical knowledge, commercial development know-how, and brand and marketing expertise to help clients evaluate opportunities, launch products and maintain brand and market leadership.
Kantar Health deeply understands the influence of patients, payers and physicians, especially as they relate to the performance and payment of medicines and the delivery of healthcare services. Its 700+ healthcare industry specialists work across the product lifecycle, from preclinical development to launch, acting as catalysts to successful decision-making in life sciences and helping clients prioritize their product development and portfolio activities, differentiate their brands and drive product success post-launch. For more information, please visit http://www.kantarhealth.com.